Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Forecasted Expansion Rate of the Primary Care POC Diagnostics Market Over the 2025–2034 Period?
The market size for primary care POC diagnostics has seen substantial growth in the past few years. Expected to rise from $16.46 billion in 2024 to $17.78 billion in 2025, it predicts a compound annual growth rate (CAGR) of 8.0%. Factors such as the growing incidence of chronic illnesses, the pivot to personalized healthcare, increased healthcare spending, improvements in regulatory support, accelerated approval processes, as well as a focus on early disease detection and prevention strategies have all attributed to the growth during the historic period.
In the coming years, the primary care POC diagnostics market is expected to experience robust growth, with projections estimating it will rise to a worth of $23.86 billion in 2029, boasting a compound annual growth rate (CAGR) of 7.6%. Factors contributing to this predicted growth in the forecast period comprise the occurence of infectious disease outbreaks, broader applications for non-communicable diseases, a hike in adoption rates in home healthcare environments, advancements in precision medicine, expanding investments in healthcare infrastructure, a surge in the overall disease burden, and an elevated awareness regarding the significance of early disease detection. Key trends for the forecast period encompass incorporating artificial intelligence (AI) and machine learning algorithms, technological progress in molecular diagnostics, miniaturizing and making POC diagnostic devices more portable, integrating intelligent devices, and employing multiplexing and panel testing in POC diagnostics.
What External and Internal Drivers Are Contributing to the Growth of the Primary Care POC Diagnostics Market’s Growth?
The upsurge in the incidence of contagious diseases is predicted to boost the progression of the primary care POC diagnostics market in the future. Contagious diseases are conditions brought on by disease-causing microorganisms such as bacteria, viruses, parasites, or fungi. These illnesses can be transmitted from one individual to another either directly or indirectly through exposure to polluted surfaces, air, water, or vectors like insects. Poor environmental conditions, urbanization, antimicrobial resistance, and insufficient vaccination protection are the primary causes behind the high incidence of these diseases. Primary care POC diagnostics play a critical role in controlling the incidence of contagious diseases, as they allow for early detection, prompt treatment, and efficient disease management mechanisms in various healthcare provisions. For example, a report by the UK Health Security Agency, a UK Government body responsible for public health security management, showed that there was a 22% increase in HIV diagnoses in England from 3,118 in 2021 to 3,805 in 2022, as per the data revealed in October 2023. Furthermore, in November 2023, the World Health Organization (WHO), a specialized agency of the United Nations headquartered in Switzerland and tasked with international public health, reported approximately 10.6 million instances of tuberculosis (TB) worldwide in 2022, which affected 5.8 million men, 3.5 million women, and 1.3 million children. As such, the increased incidence of contagious diseases is stimulating the growth of the primary care POC diagnostics market.
Request Your Free Primary Care POC Diagnostics Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15642&type=smp
Who Are the Leading Organizations Fueling the Expansion of the Primary Care POC Diagnostics Market?
Major companies operating in the primary care POC diagnostics market are:
• Hoffmann-La Roche Ltd._x000D_
• Abbott Laboratories_x000D_
• Siemens Healthineers AG_x000D_
• Becton_x000D_
• Dickinson And Company_x000D_
Which Cutting-Edge Trends Are Expected to Drive the Primary Care POC Diagnostics Market’s Growth?
Prominent companies within the primary care POC diagnostics market are pivoting towards technological innovations like portable point-of-care RT-PCR solutions in a bid to increase their market earnings. This mobile, compact device has been developed to carry out real-time reverse transcription polymerase chain reaction (RT-PCR) tests in settings outside traditional laboratories. Genes2Me Pvt. Ltd, an Indian molecular diagnostic solutions company, in October 2022, for instance, introduced its Rapi-Q Point of Care RT PCR solution, geared towards combating diseases such as HPV and tuberculosis. The Rapi-Q system, touted for its ease of use and rapid results delivery in under 45 minutes, employs an eight-well block design with four fluorescent channels. Its portability and reduced weight make it an optimal choice for medical institutions like hospitals, health clinics, blood banks, research labs, and airports. It prides itself on high precision, accuracy, and efficiency in disease detection and supports more than 50 lyophilized, room-temperature disease detection kits.
Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/primary-care-poc-diagnostics-global-market-report
What Are the Main Segments of the Primary Care POC Diagnostics Market, and How Are They Evolving?
The primary care POC diagnostics market covered in this report is segmented –
1) By Product: Glucose Monitoring, Cardiometabolic Testing Products, Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products, Tumor Or Cancer Marker Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Other Products
2) By Prescription: Prescription Based, Over-The-Counter (OTC) Testing
3) By End-Use: Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings, Other End-Uses
Subsegments:
1) By Glucose Monitoring: Blood Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Test Strips For Glucose Meters, Glucose Control Solutions
2) By Cardiometabolic Testing Products: Blood Pressure Monitors, Lipid Profile Testing Kits, Hemoglobin A1c Testing Kits, Ecg Or Ecg Monitors, Hba1c Point-Of-Care Devices
3) By Infectious Disease Testing Products: Rapid Strep Tests, Influenza (Flu) Testing Kits, Covid-19 Rapid Tests, Hiv Rapid Testing Kits, Hepatitis Testing Kits, Malaria Rapid Diagnostic Tests (Rdts), Other Infectious Disease Tests
4) By Coagulation Testing Products: Prothrombin Time (Pt) Testing Kits, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Testing Kits, Coagulation Control Solutions, Whole Blood Coagulation Monitors
5) By Pregnancy And Fertility Testing Products: Home Pregnancy Tests (Urine-Based), Ovulation Prediction Kits, Pregnancy Test Strips, Fertility Monitoring Devices
6) By Tumor Or Cancer Marker Testing Products: Psa (Prostate-specific Antigen) Testing Kits, Cea (Carcinoembryonic Antigen) Testing Kits, Ca-125 (Ovarian Cancer Marker) Kits, Her2 Testing Kits, Other Tumor Marker Test Kits
7) By Cholesterol Testing Products: Total Cholesterol Testing Kits, Ldl Or Hdl Testing Kits, Triglyceride Testing Kits, Point-Of-Care Lipid Panel Devices
8) By Hematology Testing Products: Hemoglobin Test Kits, Hematocrit Testing Kits, Complete Blood Count (Cbc) Kits, Point-Of-Care Hematology Analyzers, Hemoglobin A1c Testing Devices
9) By Drug-Of-Abuse (Doa) Testing Products: Urine Drug Tests, Oral Fluid Drug Tests, Saliva-Based Drug Tests, Blood-Based Drug Tests, Breath Alcohol Tests
10) By Other Products: Allergy Testing Kits, Urinalysis Test Strips, Vitamin And Mineral Deficiency Testing Kits, Point-Of-Care Liver Function Tests, Kidney Function Testing Products, Blood Gas Testing Devices
Which Regions Are Most Influential in Expanding the Primary Care POC Diagnostics Market?
North America was the largest region in the primary care POC diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary care POC diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
How Is the Primary Care POC Diagnostics Market Categorized and Defined in the Industry?
A primary care point-of-care (POC) diagnostic is a medical test or assessment performed conveniently and quickly within a primary care setting, such as a doctor’s office or a clinic, without requiring specialized equipment or extensive laboratory processing. These diagnostics are designed to provide rapid results, allowing healthcare providers to make timely decisions about patient care during the initial consultation.
Browse Through More Similar Reports By The Business Research Company:
Blood Transfusion Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Breast Cancer Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/breast-cancer-diagnostics-global-market-report
Molecular Diagnostics Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
